Revenue
2010
2011
2012
2013
2015
2016
2016
2017
2017
2018
2019
2020
2021
2022
2023
2024
2025
Astrana Health, Inc. (ASTH)
Price$37.84Cached quote
Net income
2010
2011
2012
2013
2015
2016
2016
2017
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2010
2011
2012
2013
2015
2016
2016
2017
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2010
2011
2012
2013
2015
2016
2016
2017
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 · Dec 31 | 2017 · Mar 31 | 2016 · Dec 31 | 2016 · Mar 31 | 2015 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.18B | $2.03B | $1.39B | $1.14B | $773.9M | $687.2M | $560.6M | $519.9M | $356.4M | $57.4M | $305.9M | $44.0M | $33.0M | $10.5M | $7.8M | $5.1M | $3.9M |
| Gross profit | $341.5M | $271.4M | $215.0M | $199.5M | $177.8M | $148.0M | $92.8M | $158.8M | $82.9M | $8.7M | $51.2M | $10.0M | $10.9M | $1.4M | $1.5M | $978,407 | $581,862 |
| Gross margin | 10.73% | 13.34% | 15.50% | 17.43% | 22.97% | 21.53% | 16.56% | 30.54% | 23.26% | 15.14% | 16.72% | 22.81% | 33.11% | 13.43% | 18.77% | 19.14% | 14.93% |
| Operating expenses | $3.10B | $1.95B | $1.30B | $1.04B | $675.7M | $606.7M | $528.2M | $431.5M | $321.2M | $68.0M | $294.2M | $51.3M | $33.7M | $14.4M | $3.5M | $1.4M | $577,847 |
| Operating income | $78.5M | $89.3M | $84.6M | $104.3M | $98.2M | $80.5M | $32.4M | $88.4M | $35.1M | −$10.5M | $11.7M | −$7.3M | −$694,334 | −$3.9M | −$2.1M | −$413,335 | $4,015 |
| Operating margin | 2.47% | 4.39% | 6.10% | 9.11% | 12.69% | 11.71% | 5.78% | 17.01% | 9.86% | −18.35% | 3.82% | −16.50% | −2.10% | −37.29% | −26.73% | −8.09% | 0.10% |
| EBITDA | $124.3M | $117.3M | $102.4M | $121.8M | $115.7M | $98.9M | $50.7M | $107.7M | $54.2M | −$9.9M | $29.8M | −$6.9M | −$359,900 | −$3.9M | −$2.1M | −$400,746 | $15,213 |
| EBITDA margin | 3.91% | 5.76% | 7.38% | 10.65% | 14.95% | 14.39% | 9.04% | 20.72% | 15.22% | −17.22% | 9.74% | −15.70% | −1.09% | −36.99% | −26.46% | −7.84% | 0.39% |
| Net income | $22.5M | $43.1M | $60.7M | $45.2M | $68.9M | $37.7M | $14.1M | $10.8M | $25.8M | −$9.0M | $11.5M | −$9.3M | −$1.8M | −$5.0M | −$8.9M | −$720,346 | −$156,331 |
| Net profit margin | 0.71% | 2.12% | 4.38% | 3.95% | 8.91% | 5.48% | 2.52% | 2.08% | 7.24% | −15.62% | 3.74% | −21.21% | −5.46% | −47.88% | −114.51% | −14.09% | −4.01% |
| Basic EPSper basic share | $0.46 | $0.91 | $1.30 | $1.00 | $1.57 | $1.03 | $0.41 | $0.33 | $1.01 | -$1.49 | $0.46 | -$1.79 | -$0.37 | -$1.37 | -$2.70 | -$0.20 | -$0.10 |
| Diluted EPSper diluted share | $0.46 | $0.90 | $1.29 | $0.99 | $1.52 | $1.01 | $0.39 | $0.29 | $0.90 | -$1.49 | $0.41 | -$1.79 | -$0.37 | -$1.37 | -$2.70 | -$0.20 | -$0.10 |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
Lam Thomas S. | 7.73M |
Sim Kenneth T. | 7.69M |
BlackRock, Inc. | 6.9M |
ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp | 6.13M |
VANGUARD PORTFOLIO MANAGEMENT LLC | 2.61M |
VANGUARD CAPITAL MANAGEMENT LLC | 1.95M |
Sim Brandon | 1.9M |
STATE STREET CORP | 1.74M |
325 CAPITAL LLC | 1.61M |
DIMENSIONAL FUND ADVISORS LP | 1.47M |
WELLINGTON MANAGEMENT GROUP LLP | 1.29M |
GEODE CAPITAL MANAGEMENT, LLC | 1.17M |
BANK OF AMERICA CORP /DE/ | 852.15K |
FMR LLC | 685.92K |
WELLS FARGO & COMPANY/MN | 664.94K |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 652.67K |
AMERIPRISE FINANCIAL INC | 512.11K |
NORTHERN TRUST CORP | 505.04K |
Diamond Hill Capital Management, LLC (Investment Advisor) | 475.94K |
ROYCE & ASSOCIATES LP | 472.48K |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data